206 related articles for article (PubMed ID: 22231291)
1. XMRV and prostate cancer--a 'final' perspective.
Sfanos KS; Aloia AL; De Marzo AM; Rein A
Nat Rev Urol; 2012 Jan; 9(2):111-8. PubMed ID: 22231291
[TBL] [Abstract][Full Text] [Related]
2. Recombinant origin of the retrovirus XMRV.
Paprotka T; Delviks-Frankenberry KA; Cingöz O; Martinez A; Kung HJ; Tepper CG; Hu WS; Fivash MJ; Coffin JM; Pathak VK
Science; 2011 Jul; 333(6038):97-101. PubMed ID: 21628392
[TBL] [Abstract][Full Text] [Related]
3. Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1.
Das Gupta J; Luk KC; Tang N; Gaughan C; Klein EA; Kandel ES; Hackett J; Silverman RH
PLoS One; 2012; 7(5):e36072. PubMed ID: 22615748
[TBL] [Abstract][Full Text] [Related]
4. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.
Lee D; Das Gupta J; Gaughan C; Steffen I; Tang N; Luk KC; Qiu X; Urisman A; Fischer N; Molinaro R; Broz M; Schochetman G; Klein EA; Ganem D; Derisi JL; Simmons G; Hackett J; Silverman RH; Chiu CY
PLoS One; 2012; 7(9):e44954. PubMed ID: 23028701
[TBL] [Abstract][Full Text] [Related]
5. What can academia learn from XMRV studies?
Pan C; Ma X; Jiang S
Nat Rev Urol; 2012 Feb; 9(3):174; author reply 174. PubMed ID: 22331091
[No Abstract] [Full Text] [Related]
6. Disease-associated XMRV sequences are consistent with laboratory contamination.
Hué S; Gray ER; Gall A; Katzourakis A; Tan CP; Houldcroft CJ; McLaren S; Pillay D; Futreal A; Garson JA; Pybus OG; Kellam P; Towers GJ
Retrovirology; 2010 Dec; 7(1):111. PubMed ID: 21171979
[TBL] [Abstract][Full Text] [Related]
7. Recombinant origin, contamination, and de-discovery of XMRV.
Delviks-Frankenberry K; Cingöz O; Coffin JM; Pathak VK
Curr Opin Virol; 2012 Aug; 2(4):499-507. PubMed ID: 22818188
[TBL] [Abstract][Full Text] [Related]
8. XMRV: a new virus in prostate cancer?
Aloia AL; Sfanos KS; Isaacs WB; Zheng Q; Maldarelli F; De Marzo AM; Rein A
Cancer Res; 2010 Dec; 70(24):10028-33. PubMed ID: 20966126
[TBL] [Abstract][Full Text] [Related]
9. No evidence of XMRV in prostate cancer cohorts in the Midwestern United States.
Sakuma T; Hué S; Squillace KA; Tonne JM; Blackburn PR; Ohmine S; Thatava T; Towers GJ; Ikeda Y
Retrovirology; 2011 Mar; 8():23. PubMed ID: 21447170
[TBL] [Abstract][Full Text] [Related]
10. No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan.
Furuta RA; Miyazawa T; Sugiyama T; Kuratsune H; Ikeda Y; Sato E; Misawa N; Nakatomi Y; Sakuma R; Yasui K; Yamaguti K; Hirayama F
Retrovirology; 2011 Mar; 8():20. PubMed ID: 21414229
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.
Arredondo M; Hackett J; de Bethencourt FR; Treviño A; Escudero D; Collado A; Qiu X; Swanson P; Soriano V; de Mendoza C
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1089-94. PubMed ID: 22206583
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence for a role of xenotropic murine leukemia virus-related virus in the pathogenesis of prostate cancer and/or chronic fatigue syndrome.
Hong P; Li J
Virus Res; 2012 Jul; 167(1):1-7. PubMed ID: 22531412
[TBL] [Abstract][Full Text] [Related]
13. Mouse DNA contamination in human tissue tested for XMRV.
Robinson MJ; Erlwein OW; Kaye S; Weber J; Cingoz O; Patel A; Walker MM; Kim WJ; Uiprasertkul M; Coffin JM; McClure MO
Retrovirology; 2010 Dec; 7():108. PubMed ID: 21171966
[TBL] [Abstract][Full Text] [Related]
14. No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
Stieler K; Schindler S; Schlomm T; Hohn O; Bannert N; Simon R; Minner S; Schindler M; Fischer N
PLoS One; 2011; 6(10):e25592. PubMed ID: 22022417
[TBL] [Abstract][Full Text] [Related]
15. Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection.
Garson JA; Kellam P; Towers GJ
Retrovirology; 2011 Feb; 8():13. PubMed ID: 21352548
[TBL] [Abstract][Full Text] [Related]
16. Detection of Xenotropic murine leukemia virus-related virus in prostate biopsy samples.
Baig FA; Mirza T; Khanani R; Khan S
J Coll Physicians Surg Pak; 2014 Sep; 24(9):636-9. PubMed ID: 25233966
[TBL] [Abstract][Full Text] [Related]
17. Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact.
Yang J; Battacharya P; Singhal R; Kandel ES
Oncotarget; 2011 May; 2(5):358-62. PubMed ID: 21642749
[TBL] [Abstract][Full Text] [Related]
18. No association between XMRV or related gammaretroviruses in Australian prostate cancer patients.
Rezaei SD; Hearps AC; Mills J; Pedersen J; Tachedjian G
Virol J; 2013 Jan; 10():20. PubMed ID: 23305518
[TBL] [Abstract][Full Text] [Related]
19. No association of xenotropic murine leukemia virus-related viruses with prostate cancer.
Switzer WM; Jia H; Zheng H; Tang S; Heneine W
PLoS One; 2011 May; 6(5):e19065. PubMed ID: 21573232
[TBL] [Abstract][Full Text] [Related]
20. Xenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood Supply.
Johnson AD; Cohn CS
Clin Microbiol Rev; 2016 Oct; 29(4):749-57. PubMed ID: 27358491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
